Replies to post #9946 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Is the transcript wrong? It wouldn't surprise me.


""As we’ve announced, we have three biosimilar products in development under our collaboration with Baxter; M923 and M834 target autoimmune and inflammatory indications. And M511 is monoclonal antibody bronchology indication.""""


Xolair